Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Calcium signaling pathway (mmu04020)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1500003O
03Rik
KLA  ATP  ATP+KLA
 NM_019769 RIKEN cDNA 1500003O03 gene (1500003O03Rik), mRNA [NM_019769] KLA .92 .89 .89 .86 .85 .92 1.08
ATP 1.01 1.16 1.16 1.53 1.70 3.33 2.09
KLA/ATP .89 .97 .93 1.17 1.19 2.86 2.57
2010110P
09Rik
KLA  ATP  ATP+KLA
 NM_027363 RIKEN cDNA 2010110P09 gene (2010110P09Rik), mRNA [NM_027363] KLA .99 .98 1.02 .99 .94 1.01 1.01
ATP 1.04 1.05 .97 1.05 .95 .98 .95
KLA/ATP .93 1.00 1.02 .97 1.01 .96 .97
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adora2a
KLA  ATP  ATP+KLA
 NM_009630 adenosine A2a receptor (Adora2a), mRNA [NM_009630] KLA 9.23 9.88 9.08 9.21 9.36 7.45 8.23
ATP 1.09 1.01 1.36 2.05 4.26 8.29 1.91
KLA/ATP 9.17 11.00 9.06 9.28 10.88 11.46 9.73
Adora2b
KLA  ATP  ATP+KLA
 NM_007413 adenosine A2b receptor (Adora2b), mRNA [NM_007413] KLA 2.50 3.09 4.71 7.11 7.38 4.18 3.17
ATP .98 1.02 1.16 4.52 8.81 7.95 2.66
KLA/ATP 2.56 3.38 4.49 5.78 7.34 7.41 6.23
Adra1a
KLA  ATP  ATP+KLA
 NM_013461 adrenergic receptor, alpha 1a (Adra1a), mRNA [NM_013461] KLA .78 .74 .75 .85 .96 1.37 2.70
ATP 1.05 1.14 .97 .97 1.69 1.06 2.56
KLA/ATP .76 .75 .83 .84 1.51 1.34 4.08
Adra1b
KLA  ATP  ATP+KLA
 NM_007416 adrenergic receptor, alpha 1b (Adra1b), mRNA [NM_007416] KLA 1.04 .99 .98 1.02 .99 1.00 1.01
ATP 1.00 .99 .98 1.01 1.06 1.01 1.05
KLA/ATP .99 .97 1.03 1.03 1.00 .97 1.08
Adra1d
KLA  ATP  ATP+KLA
 NM_013460 adrenergic receptor, alpha 1d (Adra1d), mRNA [NM_013460] KLA 1.13 1.12 1.21 1.25 1.30 1.34 1.27
ATP 1.02 .99 1.16 1.08 1.13 1.11 1.06
KLA/ATP 1.15 1.10 1.20 1.14 1.24 1.16 1.13
Adrb1
KLA  ATP  ATP+KLA
 NM_007419 adrenergic receptor, beta 1 (Adrb1), mRNA [NM_007419] KLA .88 .86 .88 .86 .87 .87 .87
ATP .97 .97 .95 .89 .89 .90 .87
KLA/ATP .90 .88 .91 .84 .91 .79 .82
Adrb2
KLA  ATP  ATP+KLA
 NM_007420 adrenergic receptor, beta 2 (Adrb2), mRNA [NM_007420] KLA .28 .26 .32 .31 .34 .31 .29
ATP 2.09 2.43 2.74 1.72 .96 .63 .29
KLA/ATP .28 .29 .52 .69 .65 .35 .23
Agtr1a
KLA  ATP  ATP+KLA
 NM_177322 angiotensin II receptor, type 1a (Agtr1a), mRNA [NM_177322] KLA 1.04 1.00 1.00 1.03 1.03 .95 1.00
ATP .98 .99 1.00 1.00 .95 1.05 1.06
KLA/ATP 1.00 .97 1.03 .97 .99 .96 .98
Agtr1b
KLA  ATP  ATP+KLA
 NM_175086 angiotensin II receptor, type 1b (Agtr1b), mRNA [NM_175086] KLA 1.02 .94 1.04 1.01 1.01 1.00 .95
ATP .97 1.01 1.03 .95 .98 1.09 1.02
KLA/ATP .94 .99 .99 .97 .99 .95 1.12
AK036998
KLA  ATP  ATP+KLA
 AK036998 adult female vagina cDNA, RIKEN full-length enriched library, clone:9930034M05 product:unclassifiable, full insert sequence. [AK036998] KLA 1.43 1.09 .89 .79 .96 .97 .71
ATP 1.04 1.04 .71 .64 .90 .82 .82
KLA/ATP 1.34 1.23 1.01 .89 1.10 .82 .75
AK043675
KLA  ATP  ATP+KLA
 AK043675 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830019B06 product:unclassifiable, full insert sequence. [AK043675] KLA 1.07 1.05 1.00 .98 1.05 1.02 1.00
ATP .92 1.07 .99 .93 1.01 1.01 1.02
KLA/ATP .96 .93 1.08 1.00 .94 .97 1.02
AK045358
KLA  ATP  ATP+KLA
 AK045358 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230105H23 product:voltage-dependent anion channel 3, full insert sequence [AK045358] KLA .96 .98 .96 .96 1.02 1.03 1.01
ATP .97 .95 1.01 .99 1.08 1.01 .97
KLA/ATP .99 .99 .98 1.01 .99 1.06 .99
Atp2a1
KLA  ATP  ATP+KLA
 NM_007504 ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 (Atp2a1), mRNA [NM_007504] KLA 1.05 1.05 1.02 .99 1.04 1.07 1.27
ATP 1.02 1.13 .96 1.13 1.10 1.17 1.12
KLA/ATP 1.15 1.11 .90 1.12 .93 1.14 .99
Atp2a2
KLA  ATP  ATP+KLA
 NM_001110140 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 1, mRNA [NM_001110140] KLA .95 1.07 .96 .84 1.17 1.16 1.53
ATP 1.16 1.27 .80 1.14 1.10 1.23 1.35
KLA/ATP 1.14 1.10 .54 1.15 .91 1.10 1.01
Atp2a2
KLA  ATP  ATP+KLA
 NM_009722 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 2, mRNA [NM_009722] KLA .90 .90 .99 .96 1.28 1.09 1.29
ATP 1.09 1.12 .94 1.19 1.47 1.36 .98
KLA/ATP .98 .95 .72 1.06 1.44 1.30 .88
Atp2a3
KLA  ATP  ATP+KLA
 NM_016745 ATPase, Ca++ transporting, ubiquitous (Atp2a3), mRNA [NM_016745] KLA 1.10 1.12 1.17 1.14 .99 .85 .54
ATP 1.05 1.11 1.15 1.32 1.14 1.00 .60
KLA/ATP 1.21 1.22 1.31 1.26 1.05 .88 .63
Atp2b1
KLA  ATP  ATP+KLA
 AK053569 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111D10 product:unclassifiable, full insert sequence. [AK053569] KLA 1.18 1.02 .86 .87 .88 .99 .97
ATP 1.38 1.60 8.03 2.45 1.66 1.16 .94
KLA/ATP 1.32 1.41 6.67 1.98 1.15 1.08 .96
Atp2b1
KLA  ATP  ATP+KLA
 AK161995 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720440F18 product:Plasma membrane calcium pump isoform 1b (Fragment) homolog [Canis familiaris], full insert sequence. [AK16199 KLA 1.64 1.50 1.23 1.02 .71 .75 .92
ATP 1.04 1.12 1.69 1.64 1.34 1.03 .66
KLA/ATP 1.69 1.58 2.20 1.99 1.03 .67 .57
Atp2b1
KLA  ATP  ATP+KLA
 NM_026482 ATPase, Ca++ transporting, plasma membrane 1 (Atp2b1), mRNA [NM_026482] KLA 1.91 1.76 1.64 1.21 .84 .79 1.07
ATP 1.00 1.01 1.43 2.32 2.28 1.71 1.06
KLA/ATP 1.86 1.85 2.23 2.48 1.71 1.05 1.04
Atp2b2
KLA  ATP  ATP+KLA
 NM_009723 ATPase, Ca++ transporting, plasma membrane 2 (Atp2b2), transcript variant 1, mRNA [NM_009723] KLA 1.02 .93 1.01 1.01 1.04 1.00 1.09
ATP 1.00 1.03 1.01 1.05 1.05 1.04 .90
KLA/ATP .99 .95 1.04 1.06 1.01 .99 1.00
Atp2b3
KLA  ATP  ATP+KLA
 AK032322 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430519O13 product:PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASE 3 (EC 3.6.3.8) (PMCA3) (PLASMA MEMBRANE CALCIUM PUMP ISOFORM 3) (PLASMA MEMBRANE CALCIUM ATPASE ISOF KLA 1.00 1.05 1.01 1.09 1.00 1.04 1.09
ATP 1.02 .97 1.01 1.12 .95 1.19 1.16
KLA/ATP 1.01 .95 .97 1.09 1.12 1.06 1.14
Avpr1a
KLA  ATP  ATP+KLA
 NM_016847 arginine vasopressin receptor 1A (Avpr1a), mRNA [NM_016847] KLA 1.00 1.07 .95 .99 1.01 1.01 1.00
ATP .99 .94 1.01 1.08 1.01 1.06 .99
KLA/ATP 1.10 .98 1.04 1.00 .99 1.05 1.00
Avpr1b
KLA  ATP  ATP+KLA
 NM_011924 arginine vasopressin receptor 1B (Avpr1b), mRNA [NM_011924] KLA 1.01 .93 .97 1.03 1.00 .97 1.01
ATP .99 1.02 1.05 1.03 1.01 1.04 1.06
KLA/ATP .93 1.00 .97 .97 .92 .96 1.04
Bdkrb1
KLA  ATP  ATP+KLA
 NM_007539 bradykinin receptor, beta 1 (Bdkrb1), mRNA [NM_007539] KLA 1.60 1.44 1.47 1.36 1.29 1.38 1.04
ATP 1.05 .99 1.17 1.12 1.15 1.16 .95
KLA/ATP 1.51 1.59 1.94 1.30 1.22 1.23 1.20
Bdkrb2
KLA  ATP  ATP+KLA
 NM_009747 bradykinin receptor, beta 2 (Bdkrb2), mRNA [NM_009747] KLA .97 .96 1.01 1.09 1.01 1.00 1.08
ATP 1.07 .98 1.04 1.01 1.05 1.00 1.08
KLA/ATP 1.02 1.05 1.04 1.01 1.03 1.04 .98
Bst1
KLA  ATP  ATP+KLA
 NM_009763 bone marrow stromal cell antigen 1 (Bst1), mRNA [NM_009763] KLA 2.26 2.15 2.90 3.73 4.89 5.96 6.57
ATP 1.05 1.06 1.31 1.52 1.57 4.31 4.76
KLA/ATP 2.29 2.31 3.10 2.98 3.09 5.35 13.91
Cacna1a
KLA  ATP  ATP+KLA
 NM_007578 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (Cacna1a), mRNA [NM_007578] KLA .71 .66 .61 .63 .60 .71 .72
ATP 1.07 1.04 .89 1.08 .71 .56 .75
KLA/ATP .71 .72 .85 .69 .64 .63 .68
Cacna1b
KLA  ATP  ATP+KLA
 U04999 N-type calcium channel alpha1 subunit mRNA, complete cds [U04999] KLA .94 .94 .95 .88 1.09 .85 .92
ATP 1.06 1.17 1.00 1.24 1.59 1.15 1.17
KLA/ATP .91 .91 .95 .95 .90 .97 1.01
Cacna1d
KLA  ATP  ATP+KLA
 NM_001083616 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] KLA 1.57 1.58 2.50 3.62 4.55 2.93 .99
ATP 1.12 .99 .97 .94 .75 1.71 1.48
KLA/ATP 1.47 1.51 1.82 1.56 1.67 2.93 4.60
Cacna1d
KLA  ATP  ATP+KLA
 NM_028981 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] KLA 1.20 1.26 1.43 1.62 2.07 1.66 1.00
ATP 1.03 1.03 .97 .97 .93 1.20 1.26
KLA/ATP 1.16 1.12 1.10 1.14 1.08 1.44 2.56
Cacna1e
KLA  ATP  ATP+KLA
 NM_009782 calcium channel, voltage-dependent, R type, alpha 1E subunit (Cacna1e), mRNA [NM_009782] KLA 1.01 .96 1.00 1.00 1.02 .99 1.04
ATP 1.03 .96 .95 1.01 1.02 1.02 1.00
KLA/ATP 1.01 1.01 1.00 1.04 .97 1.03 1.00
Cacna1f
KLA  ATP  ATP+KLA
 NM_019582 calcium channel, voltage-dependent, alpha 1F subunit (Cacna1f), mRNA [NM_019582] KLA 1.03 .98 1.05 1.06 1.00 1.02 1.01
ATP 1.05 1.05 .95 .98 .97 .96 1.01
KLA/ATP 1.01 1.03 .94 1.01 1.01 1.00 .99
Cacna1g
KLA  ATP  ATP+KLA
 NM_009783 calcium channel, voltage-dependent, T type, alpha 1G subunit (Cacna1g), transcript variant 1, mRNA [NM_009783] KLA .98 .96 .95 1.02 .99 1.03 1.01
ATP .95 .98 1.03 1.00 1.01 1.01 1.01
KLA/ATP 1.00 .97 .93 .99 .94 1.00 1.06
Cacna1h
KLA  ATP  ATP+KLA
 NM_021415 calcium channel, voltage-dependent, T type, alpha 1H subunit (Cacna1h), mRNA [NM_021415] KLA 1.07 1.00 1.04 1.01 1.02 .98 1.06
ATP .97 .96 1.05 1.00 1.00 .96 .99
KLA/ATP 1.00 .99 .96 .98 .96 .97 .92
Cacna1i
KLA  ATP  ATP+KLA
 NM_001044308 calcium channel, voltage-dependent, alpha 1I subunit (Cacna1i), mRNA [NM_001044308] KLA 1.02 .96 1.01 .98 1.00 1.05 .90
ATP .98 1.00 1.05 .98 1.04 .95 .99
KLA/ATP .97 .94 1.02 1.03 1.03 1.03 1.01
Cacna1s
KLA  ATP  ATP+KLA
 NM_001081023 calcium channel, voltage-dependent, L type, alpha 1S subunit (Cacna1s), mRNA [NM_001081023] KLA 1.03 1.01 .96 1.06 1.00 1.00 1.05
ATP 1.01 .98 1.02 1.02 1.05 1.07 1.05
KLA/ATP .99 1.05 1.02 1.05 1.03 1.05 1.00
Calm1
KLA  ATP  ATP+KLA
 NM_009790 calmodulin 1 (Calm1), mRNA [NM_009790] KLA 1.20 1.26 1.30 1.06 1.16 1.09 1.18
ATP 1.07 1.20 1.00 1.29 .99 .64 .58
KLA/ATP 1.31 1.31 .93 1.31 .97 .83 .59
Calm2
KLA  ATP  ATP+KLA
 NM_007589 calmodulin 2 (Calm2), mRNA [NM_007589] KLA .79 .81 .71 .67 .54 .45 .64
ATP .99 1.03 1.04 .93 .82 .52 .76
KLA/ATP .76 .78 .76 .77 .73 .47 .42
Calm3
KLA  ATP  ATP+KLA
 NM_007590 calmodulin 3 (Calm3), mRNA [NM_007590] KLA .95 .96 .93 1.03 1.05 1.08 1.00
ATP .93 .96 .99 .97 .93 .84 .72
KLA/ATP .89 .93 .90 .91 1.02 .98 .70
Calm4
KLA  ATP  ATP+KLA
 NM_020036 calmodulin 4 (Calm4), mRNA [NM_020036] KLA 1.02 .96 1.05 1.00 .99 1.00 1.01
ATP 1.10 1.05 1.03 1.01 .94 .98 .98
KLA/ATP .99 1.12 1.01 1.03 .98 1.07 1.02
Calm5
KLA  ATP  ATP+KLA
 NM_001008706 calmodulin 5 (Calm5), mRNA [NM_001008706] KLA 1.02 1.11 .99 .98 1.07 1.01 1.09
ATP 1.07 1.05 1.04 1.04 1.01 1.04 .99
KLA/ATP 1.00 1.00 .97 1.07 1.00 1.07 .98
Calml3
KLA  ATP  ATP+KLA
 NM_027416 calmodulin-like 3 (Calml3), mRNA [NM_027416] KLA 1.01 .95 1.05 .91 1.01 .98 .89
ATP .91 1.05 1.04 1.01 .93 1.07 .99
KLA/ATP 1.01 .96 .97 .96 .97 .92 .99
Camk2a
KLA  ATP  ATP+KLA
 NM_177407 calcium/calmodulin-dependent protein kinase II alpha (Camk2a), transcript variant 2, mRNA [NM_177407] KLA .98 .97 .98 .95 .97 1.02 .97
ATP .98 1.11 1.02 .89 .94 .89 .82
KLA/ATP .99 .95 1.02 .88 .88 .87 .87
Camk2b
KLA  ATP  ATP+KLA
 NM_007595 calcium/calmodulin-dependent protein kinase II, beta (Camk2b), mRNA [NM_007595] KLA 1.09 1.28 1.42 1.41 1.37 1.24 .68
ATP .94 .87 .95 .91 .67 .44 .48
KLA/ATP 1.16 1.24 1.40 1.13 1.14 .81 .49
Camk2d
KLA  ATP  ATP+KLA
 AK032524 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430579P05 product:calcium/calmodulin-dependent protein kinase II, delta, full insert sequence. [AK032524] KLA 1.31 1.45 1.42 1.21 1.34 1.18 1.16
ATP 1.04 1.29 1.39 1.24 .94 .91 1.22
KLA/ATP 1.46 1.64 1.42 1.24 1.00 .93 1.10
Camk2d
KLA  ATP  ATP+KLA
 NM_001025439 calcium/calmodulin-dependent protein kinase II, delta (Camk2d), transcript variant 1, mRNA [NM_001025439] KLA 1.76 1.75 1.72 1.89 1.47 1.55 1.24
ATP 1.06 1.06 .93 1.01 1.22 .98 2.28
KLA/ATP 1.84 1.78 1.40 1.57 1.07 .60 1.97
Camk2g
KLA  ATP  ATP+KLA
 NM_178597 calcium/calmodulin-dependent protein kinase II gamma (Camk2g), transcript variant 1, mRNA [NM_178597] KLA .23 .24 .23 .44 .70 .73 .70
ATP .91 .85 1.07 .86 .58 .59 .95
KLA/ATP .22 .20 .35 .25 .54 .59 .71
Camk4
KLA  ATP  ATP+KLA
 AK043457 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730097A20 product:CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE IV CATALYTIC CHAIN (EC 2.7.1.123) (CAM KINASE-GR) (CAMK IV) [CONTAINS: CALSPERMIN] homolog [Mus KLA .98 1.04 1.02 .93 1.03 1.07 1.07
ATP 1.01 .97 .97 1.10 1.00 .99 1.05
KLA/ATP 1.00 .96 1.02 .98 1.13 1.07 1.00
Camk4
KLA  ATP  ATP+KLA
 NM_009793 calcium/calmodulin-dependent protein kinase IV (Camk4), mRNA [NM_009793] KLA .96 1.02 1.01 1.02 1.03 1.07 1.08
ATP 1.01 1.03 1.07 1.08 .99 1.00 .99
KLA/ATP 1.01 .95 .98 1.08 1.12 1.02 1.03
Cckar
KLA  ATP  ATP+KLA
 NM_009827 cholecystokinin A receptor (Cckar), mRNA [NM_009827] KLA 1.00 .97 1.05 1.07 .99 1.08 1.03
ATP 1.08 1.00 1.10 1.07 .94 1.00 .98
KLA/ATP .99 .98 .99 1.04 1.00 1.04 1.02
Cckbr
KLA  ATP  ATP+KLA
 NM_007627 cholecystokinin B receptor (Cckbr), mRNA [NM_007627] KLA 1.03 1.01 1.07 1.05 1.01 1.11 1.03
ATP .94 1.04 1.04 .97 1.01 1.05 1.02
KLA/ATP 1.03 .99 1.03 1.02 1.01 1.06 1.04
Cd38
KLA  ATP  ATP+KLA
 NM_007646 CD38 antigen (Cd38), mRNA [NM_007646] KLA 3.61 5.39 8.63 9.62 24.42 36.25 76.13
ATP 1.00 1.05 1.36 1.70 2.26 8.41 7.84
KLA/ATP 4.45 4.89 5.01 7.93 5.74 14.08 40.05
Chrm1
KLA  ATP  ATP+KLA
 NM_001112697 cholinergic receptor, muscarinic 1, CNS (Chrm1), transcript variant 1, mRNA [NM_001112697] KLA 1.12 .99 .97 1.09 .92 .91 .97
ATP .95 1.06 1.01 1.06 1.05 1.06 .99
KLA/ATP 1.00 .99 1.02 1.00 1.05 .95 1.01
Chrm2
KLA  ATP  ATP+KLA
 NM_203491 cholinergic receptor, muscarinic 2, cardiac (Chrm2), mRNA [NM_203491] KLA 1.03 1.05 .98 1.02 1.04 1.06 1.05
ATP 1.09 .94 1.08 1.06 .98 1.04 .97
KLA/ATP 1.01 1.05 .97 1.01 .98 1.07 .99
Chrm3
KLA  ATP  ATP+KLA
 AK051841 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230008K23 product:unclassifiable, full insert sequence. [AK051841] KLA .92 .97 1.02 1.05 .96 .99 1.00
ATP 1.00 .99 .99 .95 1.05 1.02 1.01
KLA/ATP .91 .98 1.06 1.07 .94 1.00 .94
Chrm3
KLA  ATP  ATP+KLA
 NM_033269 cholinergic receptor, muscarinic 3, cardiac (Chrm3), mRNA [NM_033269] KLA .91 .99 .98 .93 1.08 1.01 1.06
ATP .97 1.05 1.03 .95 .99 1.01 1.10
KLA/ATP 1.05 1.09 .99 1.00 .98 1.03 1.00
Chrm5
KLA  ATP  ATP+KLA
 NM_205783 cholinergic receptor, muscarinic 5 (Chrm5), mRNA [NM_205783] KLA .98 1.02 .96 .98 1.03 1.02 1.02
ATP 1.02 .96 .96 1.15 1.00 1.06 1.04
KLA/ATP 1.02 .90 .95 1.05 1.04 1.05 .95
Chrna7
KLA  ATP  ATP+KLA
 NM_007390 cholinergic receptor, nicotinic, alpha polypeptide 7 (Chrna7), mRNA [NM_007390] KLA 1.01 .99 1.04 .96 .99 .99 1.01
ATP .99 .97 1.00 1.00 .99 1.04 1.00
KLA/ATP .98 1.02 1.04 .99 .95 .96 1.07
Cysltr1
KLA  ATP  ATP+KLA
 NM_021476 cysteinyl leukotriene receptor 1 (Cysltr1), mRNA [NM_021476] KLA 1.11 1.17 1.25 1.45 1.45 1.36 1.16
ATP .93 .87 1.03 .83 .42 .35 .71
KLA/ATP 1.01 1.03 1.13 .95 .59 .40 .61
Cysltr2
KLA  ATP  ATP+KLA
 NM_133720 cysteinyl leukotriene receptor 2 (Cysltr2), mRNA [NM_133720] KLA 3.09 2.91 3.56 3.38 2.86 3.71 3.63
ATP 1.00 .91 1.13 .96 .77 1.04 2.02
KLA/ATP 3.07 3.48 3.37 2.52 1.66 1.37 4.59
Drd1a
KLA  ATP  ATP+KLA
 NM_010076 dopamine receptor D1A (Drd1a), mRNA [NM_010076] KLA .94 .99 1.02 .98 .98 .99 1.06
ATP 1.07 1.03 1.01 1.08 1.08 .96 1.04
KLA/ATP 1.04 1.00 1.01 1.06 1.08 1.06 1.09
Drd5
KLA  ATP  ATP+KLA
 NM_013503 dopamine receptor 5 (Drd5), mRNA [NM_013503] KLA 1.00 .99 .99 .93 .97 1.04 1.03
ATP .99 1.00 1.00 1.01 1.01 1.02 1.00
KLA/ATP 1.05 .95 .98 1.00 .98 1.01 1.01
Ednra
KLA  ATP  ATP+KLA
 AK042211 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630071G03 product:SIMILAR TO ENDOTHELIN RECEPTOR TYPE A, full insert sequence. [AK042211] KLA 1.00 1.03 1.03 .97 .98 .99 .99
ATP .96 .97 1.05 .95 1.05 1.04 1.02
KLA/ATP .99 .98 1.00 1.05 .97 .98 .83
Ednra
KLA  ATP  ATP+KLA
 NM_010332 endothelin receptor type A (Ednra), mRNA [NM_010332] KLA 1.06 .99 1.02 .91 1.05 1.00 .99
ATP 1.01 .98 1.03 .98 .98 1.03 1.06
KLA/ATP 1.01 1.06 1.04 .93 .92 .92 .97
Ednrb
KLA  ATP  ATP+KLA
 NM_007904 endothelin receptor type B (Ednrb), mRNA [NM_007904] KLA 3.53 3.62 3.97 2.91 1.91 1.83 .88
ATP .97 .95 1.05 1.80 4.84 18.19 9.14
KLA/ATP 3.30 3.37 3.89 3.06 2.11 4.82 10.15
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Egfr
KLA  ATP  ATP+KLA
 NM_007912 epidermal growth factor receptor (Egfr), transcript variant 2, mRNA [NM_007912] KLA 1.10 1.07 1.14 1.11 1.08 1.03 .90
ATP .99 1.00 1.04 .98 .97 1.15 1.14
KLA/ATP 1.07 1.10 1.16 1.08 1.01 .97 .94
Egfr
KLA  ATP  ATP+KLA
 NM_207655 epidermal growth factor receptor (Egfr), transcript variant 1, mRNA [NM_207655] KLA 1.57 1.44 1.47 1.31 .96 .92 .76
ATP .97 .93 1.10 1.00 1.41 2.97 .86
KLA/ATP 1.44 1.50 1.61 1.30 1.14 1.21 .82
Erbb2
KLA  ATP  ATP+KLA
 NM_001003817 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (Erbb2), mRNA [NM_001003817] KLA 1.01 1.00 .98 1.01 .98 .99 .97
ATP .99 1.00 1.00 1.00 .96 .98 .99
KLA/ATP 1.00 1.01 1.01 1.02 .96 .98 .97
Erbb3
KLA  ATP  ATP+KLA
 BC049279 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian), mRNA (cDNA clone IMAGE:4460595), partial cds. [BC049279] KLA .71 .74 .77 .92 1.26 1.39 1.01
ATP .92 .90 .92 .70 .43 .93 1.08
KLA/ATP .66 .70 .71 .61 .56 1.15 1.29
Erbb3
KLA  ATP  ATP+KLA
 NM_010153 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (Erbb3), mRNA [NM_010153] KLA .98 .99 .98 .98 .98 1.03 1.01
ATP 1.01 1.00 .95 1.00 .94 .95 1.01
KLA/ATP .98 1.03 .95 .99 .99 .99 .93
Erbb4
KLA  ATP  ATP+KLA
 NM_010154 v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (Erbb4), mRNA [NM_010154] KLA 1.06 .98 .93 .99 1.02 .98 .91
ATP 1.01 .97 .93 .96 1.00 1.01 1.01
KLA/ATP .94 .96 1.03 .99 .87 .95 1.02
F2r
KLA  ATP  ATP+KLA
 NM_010169 coagulation factor II (thrombin) receptor (F2r), mRNA [NM_010169] KLA 3.73 3.81 3.68 3.00 2.75 1.49 1.01
ATP .98 1.02 1.25 1.24 1.31 1.63 1.16
KLA/ATP 3.51 4.05 3.49 3.00 2.48 1.69 1.23
Gna11
KLA  ATP  ATP+KLA
 NM_010301 guanine nucleotide binding protein, alpha 11 (Gna11), mRNA [NM_010301] KLA .62 .65 .69 .79 .94 1.00 .96
ATP 1.00 .94 .63 .53 .79 1.13 1.22
KLA/ATP .64 .60 .56 .55 .81 1.16 1.18
Gna14
KLA  ATP  ATP+KLA
 NM_008137 guanine nucleotide binding protein, alpha 14 (Gna14), mRNA [NM_008137] KLA .97 .96 1.07 1.00 1.01 1.04 1.02
ATP .96 1.01 1.02 1.13 1.06 1.06 .96
KLA/ATP 1.03 .95 .93 1.06 1.13 1.10 1.05
Gna15
KLA  ATP  ATP+KLA
 NM_010304 guanine nucleotide binding protein, alpha 15 (Gna15), mRNA [NM_010304] KLA 2.16 2.28 2.64 2.15 1.45 .98 .70
ATP .98 .89 .74 1.05 2.02 .97 1.07
KLA/ATP 2.18 2.11 1.63 1.66 1.69 1.17 .60
Gnal
KLA  ATP  ATP+KLA
 NM_010307 guanine nucleotide binding protein, alpha stimulating, olfactory type (Gnal), transcript variant 1, mRNA [NM_010307] KLA 1.01 .90 .96 1.20 1.02 .97 .95
ATP .96 .92 .97 1.04 1.35 1.07 1.05
KLA/ATP .90 .98 .97 1.15 1.26 1.25 1.36
Gnaq
KLA  ATP  ATP+KLA
 NM_008139 guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] KLA .82 .82 .69 .64 .60 .55 .55
ATP 1.06 1.02 .87 .67 .50 .66 .57
KLA/ATP .82 .79 .66 .55 .41 .33 .48
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Grin1
KLA  ATP  ATP+KLA
 NM_008169 glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1), mRNA [NM_008169] KLA .90 .97 .91 .98 .93 .94 1.01
ATP 1.04 1.04 1.02 1.08 .96 .91 .93
KLA/ATP .90 .99 .95 .95 .94 .88 .89
Grin2a
KLA  ATP  ATP+KLA
 NM_008170 glutamate receptor, ionotropic, NMDA2A (epsilon 1) (Grin2a), mRNA [NM_008170] KLA 1.00 1.08 1.00 1.03 1.09 1.02 1.04
ATP .96 .94 1.00 .98 1.03 .97 1.01
KLA/ATP .95 1.02 1.03 .95 .99 .99 .95
Grin2c
KLA  ATP  ATP+KLA
 NM_010350 glutamate receptor, ionotropic, NMDA2C (epsilon 3) (Grin2c), mRNA [NM_010350] KLA 1.09 1.13 1.19 1.24 1.14 1.15 1.09
ATP 1.05 .96 .98 .98 .94 1.01 1.10
KLA/ATP 1.08 1.14 1.09 1.05 1.05 .98 1.01
Grin2d
KLA  ATP  ATP+KLA
 NM_008172 glutamate receptor, ionotropic, NMDA2D (epsilon 4) (Grin2d), mRNA [NM_008172] KLA 1.57 1.18 1.35 1.45 1.25 1.49 .91
ATP .92 .99 1.45 1.66 1.54 2.02 1.15
KLA/ATP 1.23 1.38 2.08 2.28 1.92 2.53 1.92
Grm1
KLA  ATP  ATP+KLA
 NM_016976 glutamate receptor, metabotropic 1 (Grm1), transcript variant 1, mRNA [NM_016976] KLA 1.16 1.07 1.10 1.18 1.08 1.04 1.15
ATP 1.06 1.05 1.02 .99 1.00 1.09 1.02
KLA/ATP 1.04 1.12 1.06 1.11 1.10 1.32 1.35
Grm5
KLA  ATP  ATP+KLA
 NM_001081414 glutamate receptor, metabotropic 5 (Grm5), mRNA [NM_001081414] KLA 1.04 1.05 1.04 1.04 1.02 1.01 1.05
ATP .99 1.02 1.03 1.01 .99 1.00 1.03
KLA/ATP 1.03 1.02 1.02 1.03 1.01 1.01 1.05
Grpr
KLA  ATP  ATP+KLA
 NM_008177 gastrin releasing peptide receptor (Grpr), mRNA [NM_008177] KLA 1.00 .96 .99 1.03 .99 1.03 1.04
ATP .95 1.00 1.07 1.00 1.01 1.03 1.05
KLA/ATP .96 1.02 1.06 1.04 .93 1.03 .96
Hrh1
KLA  ATP  ATP+KLA
 NM_008285 histamine receptor H1 (Hrh1), mRNA [NM_008285] KLA .92 .94 .84 .88 1.27 1.69 1.61
ATP 1.05 .97 .92 .83 .85 .97 1.04
KLA/ATP .86 .89 .83 .74 .87 1.20 2.84
Hrh2
KLA  ATP  ATP+KLA
 NM_008286 histamine receptor H2 (Hrh2), transcript variant 2, mRNA [NM_008286] KLA 1.18 1.33 1.70 1.54 1.69 1.61 1.52
ATP .96 1.10 .98 1.08 .99 1.03 1.35
KLA/ATP 1.25 1.19 1.15 1.20 1.09 1.39 1.92
Htr2a
KLA  ATP  ATP+KLA
 NM_172812 5-hydroxytryptamine (serotonin) receptor 2A (Htr2a), mRNA [NM_172812] KLA 1.00 1.01 1.03 1.00 .97 .96 .99
ATP .97 .97 .95 1.12 1.41 .98 .95
KLA/ATP .92 1.01 1.07 1.08 1.03 .98 1.06
Htr2b
KLA  ATP  ATP+KLA
 NM_008311 5-hydroxytryptamine (serotonin) receptor 2B (Htr2b), mRNA [NM_008311] KLA .47 .44 .41 .46 .73 1.91 1.14
ATP .90 .92 .95 1.02 1.24 1.47 11.87
KLA/ATP .44 .43 .51 .56 1.05 4.41 10.84
Htr2c
KLA  ATP  ATP+KLA
 AK086348 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930023E13 product:5-hydroxytryptamine (serotonin) receptor 2C, full insert sequence. [AK086348] KLA 1.01 1.01 1.00 1.03 1.03 1.04 1.04
ATP 1.01 1.00 1.00 1.04 1.02 1.03 .99
KLA/ATP .99 1.02 .96 1.07 1.03 1.06 1.06
Htr2c
KLA  ATP  ATP+KLA
 NM_008312 5-hydroxytryptamine (serotonin) receptor 2C (Htr2c), mRNA [NM_008312] KLA 1.03 1.08 1.00 1.05 1.02 1.02 .98
ATP .96 1.02 1.01 1.05 .98 .99 1.03
KLA/ATP 1.00 1.00 1.04 .97 .96 .96 .98
Htr4
KLA  ATP  ATP+KLA
 NM_008313 5 hydroxytryptamine (serotonin) receptor 4 (Htr4), mRNA [NM_008313] KLA 1.02 1.05 .99 .99 1.01 .99 1.08
ATP .98 1.04 1.04 1.06 .96 1.02 1.06
KLA/ATP 1.00 .98 .97 1.03 1.02 1.08 1.00
Htr5a
KLA  ATP  ATP+KLA
 NM_008314 5-hydroxytryptamine (serotonin) receptor 5A (Htr5a), mRNA [NM_008314] KLA 1.08 1.01 1.14 1.10 1.13 1.04 1.08
ATP 1.09 .98 .96 .97 1.04 1.00 1.03
KLA/ATP 1.12 1.08 1.12 .99 1.00 1.03 .98
Htr5b
KLA  ATP  ATP+KLA
 NM_010483 5-hydroxytryptamine (serotonin) receptor 5B (Htr5b), mRNA [NM_010483] KLA .99 .98 1.01 .98 .97 .99 .98
ATP .95 1.00 1.01 1.01 1.01 1.06 .94
KLA/ATP .97 1.00 1.05 1.03 1.00 .93 1.06
Htr6
KLA  ATP  ATP+KLA
 NM_021358 5-hydroxytryptamine (serotonin) receptor 6 (Htr6), mRNA [NM_021358] KLA 1.04 1.01 1.01 1.06 1.05 .98 .97
ATP 1.00 1.03 .96 .96 1.02 .96 1.02
KLA/ATP .93 .94 1.03 1.03 .91 1.00 .91
Htr7
KLA  ATP  ATP+KLA
 NM_008315 5-hydroxytryptamine (serotonin) receptor 7 (Htr7), mRNA [NM_008315] KLA 1.07 .91 1.03 1.05 1.02 1.07 .97
ATP .97 1.02 1.00 1.03 1.05 1.05 .99
KLA/ATP 1.03 1.03 1.10 .99 .99 1.09 1.25
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Itpka
KLA  ATP  ATP+KLA
 NM_146125 inositol 1,4,5-trisphosphate 3-kinase A (Itpka), mRNA [NM_146125] KLA 6.50 5.98 5.46 4.17 2.98 2.72 1.97
ATP 1.13 .98 1.19 1.19 2.36 2.47 1.17
KLA/ATP 7.72 7.92 10.01 7.02 8.80 6.84 1.93
Itpkc
KLA  ATP  ATP+KLA
 AK051297 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130031K05 product:weakly similar to INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C [Homo sapiens], full insert sequence. [AK051297] KLA 1.15 1.02 1.00 1.09 1.07 1.03 1.00
ATP .91 1.03 1.02 .99 .98 1.03 1.02
KLA/ATP .94 .95 1.06 .99 .95 .98 1.02
Itpkc
KLA  ATP  ATP+KLA
 NM_181593 inositol 1,4,5-trisphosphate 3-kinase C (Itpkc), mRNA [NM_181593] KLA .76 .68 .76 1.00 1.61 1.01 1.14
ATP 1.18 1.09 1.14 4.49 3.58 1.64 1.04
KLA/ATP .85 .78 1.05 2.67 3.12 1.34 1.41
Itpr1
KLA  ATP  ATP+KLA
 NM_010585 inositol 1,4,5-triphosphate receptor 1 (Itpr1), mRNA [NM_010585] KLA 3.66 3.69 6.74 8.11 7.08 4.40 1.22
ATP 1.08 .95 1.19 .94 1.09 1.00 .68
KLA/ATP 3.48 3.58 5.86 6.03 4.01 2.31 .97
Itpr2
KLA  ATP  ATP+KLA
 NM_019923 inositol 1,4,5-triphosphate receptor 2 (Itpr2), transcript variant 1, mRNA [NM_019923] KLA 1.41 1.38 1.43 1.42 1.30 1.07 1.01
ATP 1.00 1.00 .97 .97 1.07 1.15 1.06
KLA/ATP 1.39 1.48 1.64 1.42 1.07 .83 .95
Itpr3
KLA  ATP  ATP+KLA
 NM_080553 inositol 1,4,5-triphosphate receptor 3 (Itpr3), mRNA [NM_080553] KLA .55 .51 .45 .41 .34 .34 .45
ATP 1.01 .92 1.02 .57 .46 .34 1.22
KLA/ATP .56 .48 .48 .29 .33 .27 .65
Lhcgr
KLA  ATP  ATP+KLA
 NM_013582 luteinizing hormone/choriogonadotropin receptor (Lhcgr), mRNA [NM_013582] KLA .98 1.06 .99 .95 1.01 1.00 1.04
ATP 1.01 .95 1.00 1.04 1.00 1.03 1.00
KLA/ATP 1.04 1.02 .97 1.01 1.03 1.04 .98
Ltb4r2
KLA  ATP  ATP+KLA
 NM_020490 leukotriene B4 receptor 2 (Ltb4r2), mRNA [NM_020490] KLA .97 1.01 1.01 .99 1.03 1.04 1.01
ATP 1.02 .91 1.07 1.01 1.08 1.03 1.01
KLA/ATP .95 1.01 1.00 1.03 1.04 1.01 1.03
Mm.13153
0
KLA  ATP  ATP+KLA
 161086915 Unknown KLA 1.00 1.07 1.14 1.08 .97 1.00 .93
ATP 1.04 .99 1.00 .95 .99 1.02 .90
KLA/ATP 1.08 1.18 1.14 1.16 1.04 1.06 1.08
Mm.1716
KLA  ATP  ATP+KLA
 46852154 Unknown KLA 1.36 1.28 1.23 1.51 1.39 1.42 1.44
ATP .94 1.00 1.10 1.38 1.43 1.20 1.04
KLA/ATP 1.24 1.32 1.36 1.46 2.16 1.59 1.47
Mm.24060
7
KLA  ATP  ATP+KLA
 162951825 Unknown KLA .94 .96 .91 1.02 .90 .84 .97
ATP 1.08 1.01 1.08 .95 1.04 .89 .89
KLA/ATP .93 1.01 1.05 .92 .84 .88 .76
Mm.24987
3
KLA  ATP  ATP+KLA
 161621251 Unknown KLA 1.11 1.02 1.08 1.36 1.47 1.64 3.59
ATP 1.05 1.00 1.00 .96 1.04 1.20 1.13
KLA/ATP 1.08 1.12 1.23 1.06 1.09 1.31 1.81
Mm.26232
7
KLA  ATP  ATP+KLA
 118130063 Unknown KLA .91 .88 .82 .99 .84 .98 .82
ATP .84 .72 .77 .54 .54 .50 .72
KLA/ATP .74 .71 .74 .50 .71 .60 .39
Mm.29073
1
KLA  ATP  ATP+KLA
 125347157 Unknown KLA .98 .99 1.12 1.02 1.04 1.04 1.05
ATP 1.02 1.06 .97 1.05 .99 1.07 1.02
KLA/ATP .96 .96 .99 1.10 1.07 1.03 1.01
Mm.29105
8
KLA  ATP  ATP+KLA
 157057193 Unknown KLA 1.02 .94 .97 .97 1.03 1.00 1.00
ATP 1.03 1.01 1.10 .95 .95 1.00 1.03
KLA/ATP .97 .93 1.06 1.02 1.04 .94 1.02
Mm.3159
KLA  ATP  ATP+KLA
 77404187 Unknown KLA .96 .95 1.06 1.00 1.00 .91 1.05
ATP 1.06 .97 .97 .96 1.02 .90 1.05
KLA/ATP .92 .99 .96 .99 .99 .99 .98
Mm.32259
4
KLA  ATP  ATP+KLA
 144922605 Unknown KLA 1.02 1.03 .98 .98 .95 1.00 1.02
ATP 1.01 .98 1.08 1.01 1.04 1.01 .97
KLA/ATP .97 1.08 1.04 1.02 1.00 1.01 1.03
Mm.33138
9
KLA  ATP  ATP+KLA
 158508469 Unknown KLA .80 .79 .81 .82 .72 .64 .50
ATP .95 .85 .56 .48 .30 .33 .46
KLA/ATP .71 .64 .50 .41 .33 .32 .42
Mm.38329
7
KLA  ATP  ATP+KLA
 124487166 Unknown KLA 2.05 2.34 2.70 2.62 3.57 3.14 2.09
ATP 1.14 1.43 1.16 2.23 1.65 1.29 1.61
KLA/ATP 2.51 2.51 1.90 3.84 2.23 2.63 3.57
Mm.42026
KLA  ATP  ATP+KLA
 84781761 Unknown KLA .55 .55 .60 .65 .79 1.01 .87
ATP .97 .99 1.03 .91 .56 .43 .56
KLA/ATP .60 .58 .68 .58 .85 .96 1.13
Mm.44160
1
KLA  ATP  ATP+KLA
 145966786 Unknown KLA 1.08 .94 1.01 .97 .79 .78 .71
ATP 1.09 .92 1.10 .75 .65 .92 .69
KLA/ATP 1.01 .92 1.16 .81 .69 .56 .63
Mm.4424
KLA  ATP  ATP+KLA
 110225367 Unknown KLA .99 .93 1.01 1.02 1.00 .92 1.00
ATP .98 1.03 3.11 1.13 1.19 1.03 1.11
KLA/ATP .95 .97 .97 .96 .93 1.01 .99
Mm.44463
KLA  ATP  ATP+KLA
 118129851 Unknown KLA 1.01 .98 .97 1.02 .93 1.06 1.05
ATP .97 1.01 1.04 1.06 1.02 1.08 .97
KLA/ATP 1.02 1.06 .95 1.04 1.09 1.14 1.03
Mm.54161
KLA  ATP  ATP+KLA
 164607143 Unknown KLA .97 .99 1.00 .98 .95 .98 .94
ATP 1.01 .99 1.06 1.07 1.02 .95 .98
KLA/ATP .93 1.04 1.07 .96 .90 .95 .94
Mylk
KLA  ATP  ATP+KLA
 AK044527 adult retina cDNA, RIKEN full-length enriched library, clone:A930019C19 product:MYOSIN LIGHT CHAIN KINASE (FRAGMENT) homolog [Mus musculus], full insert sequence. [AK044527] KLA 1.10 .99 .93 1.01 1.00 1.07 1.01
ATP 1.02 .97 .92 .99 1.02 .97 1.06
KLA/ATP 1.01 1.03 1.05 .97 .91 1.00 .96
Mylk
KLA  ATP  ATP+KLA
 NM_139300 myosin, light polypeptide kinase (Mylk), mRNA [NM_139300] KLA 1.05 1.15 1.22 1.24 1.33 1.21 .50
ATP 1.05 1.08 .96 .91 .79 .71 .40
KLA/ATP 1.14 1.18 1.15 1.04 .90 .79 .48
Mylk2
KLA  ATP  ATP+KLA
 NM_001081044 myosin, light polypeptide kinase 2, skeletal muscle (Mylk2), mRNA [NM_001081044] KLA 1.17 1.21 1.11 1.25 1.17 1.10 1.06
ATP .94 1.05 1.06 1.10 1.33 1.33 1.27
KLA/ATP 1.15 1.25 1.14 1.21 1.32 1.29 1.45
Mylk3
KLA  ATP  ATP+KLA
 AK052858 16 days neonate heart cDNA, RIKEN full-length enriched library, clone:D830007F02 product:Weakly similar to myosin light chain kinase, full insert sequence. [AK052858] KLA 1.06 1.02 .95 .98 1.01 1.04 1.02
ATP 1.02 1.06 1.00 1.01 .97 1.01 .98
KLA/ATP 1.08 1.00 .94 1.13 1.07 1.08 1.05
Nos1
KLA  ATP  ATP+KLA
 NM_008712 nitric oxide synthase 1, neuronal (Nos1), mRNA [NM_008712] KLA 1.01 1.01 1.02 .99 1.02 1.02 1.01
ATP 1.01 1.03 1.02 1.04 1.03 1.01 1.00
KLA/ATP 1.05 1.02 1.02 1.00 1.02 1.03 1.03
Nos2
KLA  ATP  ATP+KLA
 NM_010927 nitric oxide synthase 2, inducible, macrophage (Nos2), mRNA [NM_010927] KLA 13.50 16.36 25.65 23.25 24.78 15.99 6.48
ATP 1.03 1.03 1.48 1.66 1.65 5.55 1.70
KLA/ATP 16.01 17.41 19.06 25.50 20.84 29.92 29.80
Nos3
KLA  ATP  ATP+KLA
 NM_008713 nitric oxide synthase 3, endothelial cell (Nos3), mRNA [NM_008713] KLA .83 .79 .76 .78 .77 .85 .96
ATP 1.03 1.09 1.03 1.02 .85 .96 1.84
KLA/ATP .80 .78 .79 .80 .79 .78 .91
Ntsr1
KLA  ATP  ATP+KLA
 NM_018766 neurotensin receptor 1 (Ntsr1), mRNA [NM_018766] KLA 1.04 .98 .97 1.04 1.01 .98 .99
ATP .96 .99 .98 1.00 .94 .99 1.04
KLA/ATP .95 .95 1.06 .99 1.00 .93 .95
Orai1
KLA  ATP  ATP+KLA
 NM_175423 ORAI calcium release-activated calcium modulator 1 (Orai1), mRNA [NM_175423] KLA .54 .57 .51 .71 1.13 1.52 1.43
ATP 1.00 1.03 1.00 1.24 .85 1.56 1.87
KLA/ATP .56 .50 .50 .71 .77 1.26 2.53
Orai2
KLA  ATP  ATP+KLA
 NM_178751 ORAI calcium release-activated calcium modulator 2 (Orai2), mRNA [NM_178751] KLA 1.98 1.83 1.57 1.82 2.65 2.79 2.26
ATP .96 1.05 1.23 2.54 2.76 2.36 1.18
KLA/ATP 1.87 1.93 1.64 2.15 1.81 1.83 2.51
Orai3
KLA  ATP  ATP+KLA
 NM_198424 ORAI calcium release-activated calcium modulator 3 (Orai3), mRNA [NM_198424] KLA .68 .68 .77 .74 .92 .88 .93
ATP 1.10 1.10 .90 .79 .36 .35 .74
KLA/ATP .73 .73 .65 .60 .40 .32 .82
Oxtr
KLA  ATP  ATP+KLA
 D86599 gb|Mus sp. mRNA for oxytocin receptor, complete cds. [D86599] KLA 1.06 .99 1.04 1.10 1.01 .98 1.02
ATP 1.07 1.04 1.06 .96 1.02 1.01 1.00
KLA/ATP 1.01 1.00 .79 1.04 1.02 .99 1.01
Oxtr
KLA  ATP  ATP+KLA
 NM_001081147 oxytocin receptor (Oxtr), mRNA [NM_001081147] KLA 1.00 1.00 .99 .95 .99 1.00 .99
ATP 1.06 .99 1.00 1.01 .96 .97 1.03
KLA/ATP .94 1.08 1.00 1.00 .94 .94 .98
P2rx1
KLA  ATP  ATP+KLA
 NM_008771 purinergic receptor P2X, ligand-gated ion channel, 1 (P2rx1), mRNA [NM_008771] KLA .98 1.02 1.06 1.04 1.03 .94 .97
ATP 1.00 .97 1.01 .95 .99 1.05 1.03
KLA/ATP 1.08 1.00 1.03 .98 .92 1.01 1.09
P2rx2
KLA  ATP  ATP+KLA
 NM_153400 purinergic receptor P2X, ligand-gated ion channel, 2 (P2rx2), mRNA [NM_153400] KLA 1.15 1.07 1.12 1.19 1.18 1.20 .99
ATP .97 1.09 1.30 1.43 1.29 1.17 1.07
KLA/ATP 1.15 1.13 1.45 1.53 1.38 1.31 1.22
P2rx3
KLA  ATP  ATP+KLA
 AK053021 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930017N16 product:hypothetical protein, full insert sequence. [AK053021] KLA .97 .96 1.03 1.04 1.02 1.00 1.05
ATP 1.00 1.02 1.00 1.03 1.01 .96 1.02
KLA/ATP .96 1.04 .96 .91 .98 1.04 1.02
P2rx3
KLA  ATP  ATP+KLA
 NM_145526 purinergic receptor P2X, ligand-gated ion channel, 3 (P2rx3), mRNA [NM_145526] KLA .86 1.01 1.09 1.01 .99 1.10 1.14
ATP 1.03 .96 1.12 1.14 .96 1.03 .99
KLA/ATP .98 .99 1.09 1.10 1.04 1.06 1.00
P2rx4
KLA  ATP  ATP+KLA
 NM_011026 purinergic receptor P2X, ligand-gated ion channel 4 (P2rx4), mRNA [NM_011026] KLA 1.43 1.51 1.72 1.88 2.11 2.56 3.11
ATP 1.00 .99 .85 .91 .93 1.13 1.98
KLA/ATP 1.50 1.53 1.43 1.30 1.22 1.81 3.72
P2rx5
KLA  ATP  ATP+KLA
 NM_033321 purinergic receptor P2X, ligand-gated ion channel, 5 (P2rx5), mRNA [NM_033321] KLA 1.05 1.08 1.06 1.03 .99 .97 .99
ATP .92 .96 .94 .97 1.02 1.72 3.00
KLA/ATP 1.11 1.04 .98 .96 .98 1.39 2.14
P2rx6
KLA  ATP  ATP+KLA
 AK054195 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230027A21 product:purinergic receptor P2X-like 1, orphan receptor, full insert sequence. [AK054195] KLA .98 .97 1.02 1.01 1.03 1.01 .98
ATP 1.02 1.06 1.03 .95 1.05 .99 1.01
KLA/ATP .98 1.03 1.03 1.05 1.01 1.06 1.06
P2rx6
KLA  ATP  ATP+KLA
 NM_011028 purinergic receptor P2X, ligand-gated ion channel, 6 (P2rx6), mRNA [NM_011028] KLA .91 .93 .99 1.00 .94 .87 .93
ATP .98 .97 1.05 .95 .96 .91 .93
KLA/ATP 1.03 .92 .99 .88 .89 .90 .88
P2rx7
KLA  ATP  ATP+KLA
 NM_011027 purinergic receptor P2X, ligand-gated ion channel, 7 (P2rx7), transcript variant 1, mRNA [NM_011027] KLA .52 .52 .50 .59 .67 .98 .80
ATP .93 .87 1.11 .79 .57 .48 .52
KLA/ATP .50 .50 .63 .48 .87 .97 1.03
Pde1a
KLA  ATP  ATP+KLA
 NM_001009978 phosphodiesterase 1A, calmodulin-dependent (Pde1a), transcript variant 7, mRNA [NM_001009978] KLA 1.42 1.46 1.58 1.35 1.43 1.21 1.25
ATP 1.02 1.01 1.07 1.13 1.50 1.46 1.08
KLA/ATP 1.44 1.52 1.27 1.38 1.23 1.40 1.41
Pde1a
KLA  ATP  ATP+KLA
 NM_016744 phosphodiesterase 1A, calmodulin-dependent (Pde1a), mRNA [NM_016744] KLA .98 .99 1.03 1.04 1.02 .96 1.04
ATP 1.02 1.02 1.05 1.03 1.00 .98 .98
KLA/ATP .99 1.00 1.08 1.03 1.01 1.04 1.00
Pde1b
KLA  ATP  ATP+KLA
 NM_008800 phosphodiesterase 1B, Ca2+-calmodulin dependent (Pde1b), mRNA [NM_008800] KLA 1.53 1.78 1.80 1.94 2.87 2.77 1.81
ATP 1.16 1.04 .98 1.15 1.27 1.30 .81
KLA/ATP 1.71 1.80 1.46 1.38 1.25 1.92 2.12
Pde1c
KLA  ATP  ATP+KLA
 ENSMUST00000114327 ens|Calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase 1C (EC 3.1.4.17) (Cam-PDE 1C). [Source:Uniprot/SWISSPROT;Acc:Q64338] [ENSMUST00000114327] KLA .94 1.03 1.01 .96 1.09 1.05 1.04
ATP 1.06 1.04 1.02 1.04 1.02 1.03 .96
KLA/ATP .93 .96 .99 1.11 1.04 1.08 1.01
Pde1c
KLA  ATP  ATP+KLA
 NM_001025568 phosphodiesterase 1C (Pde1c), transcript variant 2, mRNA [NM_001025568] KLA .90 .87 .88 .83 .73 .72 .74
ATP .93 1.03 1.06 .92 .88 .78 .74
KLA/ATP .96 .94 .95 .91 .84 .72 .72
Pde1c
KLA  ATP  ATP+KLA
 NM_011054 phosphodiesterase 1C (Pde1c), transcript variant 1, mRNA [NM_011054] KLA .96 .98 .90 .96 .91 1.01 .93
ATP .93 .95 .99 .94 .94 .92 .95
KLA/ATP 1.00 .91 .81 1.05 1.01 .88 .88
Pdgfra
KLA  ATP  ATP+KLA
 NM_011058 platelet derived growth factor receptor, alpha polypeptide (Pdgfra), transcript variant 1, mRNA [NM_011058] KLA 1.02 1.05 1.02 1.01 1.03 1.03 1.01
ATP 1.01 1.02 1.03 1.04 1.00 1.01 1.01
KLA/ATP 1.01 1.01 .99 1.03 1.02 1.03 1.01
Pdgfrb
KLA  ATP  ATP+KLA
 NM_008809 platelet derived growth factor receptor, beta polypeptide (Pdgfrb), mRNA [NM_008809] KLA 4.85 5.49 4.56 3.94 3.71 2.05 1.51
ATP .99 1.00 1.11 1.27 1.02 1.83 1.23
KLA/ATP 5.09 5.86 4.30 2.51 1.74 1.84 3.23
Phka1
KLA  ATP  ATP+KLA
 NM_008832 phosphorylase kinase alpha 1 (Phka1), transcript variant 1, mRNA [NM_008832] KLA .89 .77 .77 .83 .74 .79 .89
ATP 1.10 1.03 .90 .88 .69 .72 .79
KLA/ATP .83 .78 .80 .70 .67 .76 .66
Phka2
KLA  ATP  ATP+KLA
 AK045618 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230216B06 product:PHOSPHORYLASE B KINASE ALPHA REGULATORY CHAIN, LIVER ISOFORM (PHOSPHORYLASE KINASE ALPHA L SUBUNIT)homolog [Homo sapiens], full insert sequ KLA .48 .47 .52 .56 .57 .60 .48
ATP .79 .70 .60 .56 .50 .49 .58
KLA/ATP .45 .46 .53 .55 .58 .48 .47
Phka2
KLA  ATP  ATP+KLA
 NM_172783 phosphorylase kinase alpha 2 (Phka2), mRNA [NM_172783] KLA .66 .67 .61 .52 .46 .48 .52
ATP 1.06 1.17 .74 .86 .45 .32 .60
KLA/ATP .76 .68 .42 .51 .31 .31 .50
Phkb
KLA  ATP  ATP+KLA
 AK089493 B6-derived CD11 +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F730039M10 product:similar to phosphorylase kinase (EC 2.7.1.38) beta chain [Homo sapiens], full insert sequence. [AK089493] KLA .90 .83 .71 .84 1.04 .89 .91
ATP .96 1.05 .83 .72 .77 .76 .85
KLA/ATP .87 .87 .76 .71 .78 .71 .77
Phkb
KLA  ATP  ATP+KLA
 NM_199446 phosphorylase kinase beta (Phkb), mRNA [NM_199446] KLA .94 .94 .95 .93 .83 .77 .79
ATP .96 1.02 .94 .86 .51 .38 .60
KLA/ATP .91 .93 .76 .71 .45 .38 .44
Phkg1
KLA  ATP  ATP+KLA
 NM_011079 phosphorylase kinase gamma 1 (Phkg1), mRNA [NM_011079] KLA 1.00 .98 1.06 1.06 .95 .99 .94
ATP 1.02 .98 .91 .99 1.00 .91 .96
KLA/ATP 1.02 1.11 1.01 .99 1.00 .92 1.09
Phkg2
KLA  ATP  ATP+KLA
 AK089062 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430038C01 product:5phosphorylase kinase, gamma 2 (testis), full insert sequence [AK089062] KLA .93 .90 .88 .86 .99 .79 .89
ATP 1.10 1.05 .68 .73 1.05 .92 .98
KLA/ATP .87 .84 .69 .79 .93 .97 1.10
Phkg2
KLA  ATP  ATP+KLA
 NM_026888 phosphorylase kinase, gamma 2 (testis) (Phkg2), mRNA [NM_026888] KLA .88 .86 .98 .96 1.13 1.02 .92
ATP 1.19 1.12 1.02 1.23 1.17 1.23 1.22
KLA/ATP 1.04 1.06 1.00 1.13 1.25 1.33 1.64
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Plcd1
KLA  ATP  ATP+KLA
 NM_019676 phospholipase C, delta 1 (Plcd1), mRNA [NM_019676] KLA 2.80 2.76 2.50 2.05 1.09 .66 1.49
ATP .93 .94 1.22 1.10 .99 1.35 .50
KLA/ATP 2.55 2.84 3.38 2.74 1.98 1.32 .80
Plcd3
KLA  ATP  ATP+KLA
 NM_152813 phospholipase C, delta 3 (Plcd3), mRNA [NM_152813] KLA .58 .56 .49 .61 .70 .74 .87
ATP .98 1.07 .91 .92 .80 .96 1.23
KLA/ATP .58 .55 .59 .61 .75 1.03 1.68
Plcd4
KLA  ATP  ATP+KLA
 NM_148937 phospholipase C, delta 4 (Plcd4), transcript variant 2, mRNA [NM_148937] KLA 1.04 .99 1.00 .99 .95 1.02 1.06
ATP .99 .98 .99 1.13 1.00 1.02 1.04
KLA/ATP 1.04 1.01 1.00 .97 1.10 .99 1.02
Plce1
KLA  ATP  ATP+KLA
 AK035546 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530064F18 product:PANCREAS-ENRICHED PHOSPHOLIPASE C homolog [Homo sapiens], full insert sequence. [AK035546] KLA .99 1.08 1.03 1.00 1.06 1.04 .97
ATP 1.04 1.01 1.02 1.01 .96 1.01 1.06
KLA/ATP .98 .98 .93 1.02 .95 .93 .97
Plce1
KLA  ATP  ATP+KLA
 BC025027 phospholipase C, epsilon 1, mRNA (cDNA clone IMAGE:4948638), with apparent retained intron. [BC025027] KLA 1.07 1.12 1.04 1.10 1.07 1.04 1.04
ATP 1.00 .96 1.06 .99 .98 .96 1.01
KLA/ATP 1.21 1.06 1.13 1.09 1.00 1.08 1.14
Plce1
KLA  ATP  ATP+KLA
 NM_019588 phospholipase C, epsilon 1 (Plce1), mRNA [NM_019588] KLA .98 1.03 .99 .96 1.01 1.04 .96
ATP .98 .99 1.02 1.13 .99 1.01 1.00
KLA/ATP .97 1.11 1.00 1.07 .93 1.06 .99
Plcg2
KLA  ATP  ATP+KLA
 NM_172285 phospholipase C, gamma 2 (Plcg2), mRNA [NM_172285] KLA .76 .74 .68 .66 .71 .92 .95
ATP .96 .90 .95 .87 .81 .79 .91
KLA/ATP .76 .71 .69 .62 .72 .78 .68
Plcz1
KLA  ATP  ATP+KLA
 NM_054066 phospholipase C, zeta 1 (Plcz1), mRNA [NM_054066] KLA 1.02 .99 .97 1.04 .98 .95 .98
ATP 1.01 1.03 1.03 .98 .97 1.00 1.04
KLA/ATP 1.02 1.04 1.03 .99 1.01 1.00 1.01
Pln
KLA  ATP  ATP+KLA
 NM_023129 phospholamban (Pln), mRNA [NM_023129] KLA 1.01 1.03 1.07 1.02 1.01 1.01 .97
ATP 1.02 1.00 .91 1.00 .98 .99 .98
KLA/ATP 1.01 1.07 1.08 .93 .99 1.01 .95
Ppif
KLA  ATP  ATP+KLA
 NM_134084 peptidylprolyl isomerase F (cyclophilin F) (Ppif), nuclear gene encoding mitochondrial protein, mRNA [NM_134084] KLA 1.06 1.10 1.37 1.26 1.55 1.32 1.54
ATP 1.08 1.07 1.15 2.39 1.83 1.20 1.17
KLA/ATP 1.17 1.17 1.33 2.50 2.70 1.72 1.06
Ppp3ca
KLA  ATP  ATP+KLA
 NM_008913 protein phosphatase 3, catalytic subunit, alpha isoform (Ppp3ca), mRNA [NM_008913] KLA .76 .85 .81 .85 .73 .70 .52
ATP .96 .78 .55 .46 .31 .33 .48
KLA/ATP .74 .64 .52 .42 .37 .36 .45
Ppp3cb
KLA  ATP  ATP+KLA
 AK135203 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720421K10 product:protein phosphatase 3, catalytic subunit, beta isoform, full insert sequence. [AK135203] KLA 1.74 1.57 1.91 1.59 1.47 1.26 1.40
ATP 1.17 1.03 1.30 1.00 .81 .62 1.37
KLA/ATP 1.68 1.70 1.91 1.37 1.09 .47 1.13
Ppp3cb
KLA  ATP  ATP+KLA
 AK171904 activated spleen cDNA, RIKEN full-length enriched library, clone:F830018L06 product:Protein phosphatase 3 catalytic subunit beta3 (EC 3.1.3.16) (Serine [AK171904] KLA 1.29 1.29 1.21 1.15 1.22 1.13 1.28
ATP .90 .86 .80 .98 .94 .73 .92
KLA/ATP 1.06 1.03 .77 1.04 .92 .68 .90
Ppp3cb
KLA  ATP  ATP+KLA
 NM_008914 protein phosphatase 3, catalytic subunit, beta isoform (Ppp3cb), mRNA [NM_008914] KLA 1.21 1.29 1.38 1.24 1.29 1.08 1.23
ATP 1.15 1.31 1.09 1.29 .86 .60 .64
KLA/ATP 1.33 1.40 1.04 1.28 .79 .58 .73
Ppp3cc
KLA  ATP  ATP+KLA
 AK037563 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130026K22 product:unclassifiable, full insert sequence [AK037563] KLA 1.27 1.18 1.21 1.15 1.01 .92 1.36
ATP .96 1.09 1.10 1.03 .85 1.06 1.47
KLA/ATP 1.17 1.24 1.07 1.13 .91 .88 1.36
Ppp3cc
KLA  ATP  ATP+KLA
 NM_008915 protein phosphatase 3, catalytic subunit, gamma isoform (Ppp3cc), mRNA [NM_008915] KLA 1.64 1.81 1.79 1.35 .90 .70 1.31
ATP .90 .90 1.13 .93 .86 1.40 1.60
KLA/ATP 1.45 1.62 1.74 1.47 1.04 1.01 1.31
Ppp3r1
KLA  ATP  ATP+KLA
 NM_024459 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) (Ppp3r1), mRNA [NM_024459] KLA 1.02 1.17 .93 1.27 1.15 1.30 1.30
ATP .97 .95 .77 .91 .99 1.18 1.10
KLA/ATP 1.12 1.04 .88 1.00 1.10 1.10 1.07
Ppp3r2
KLA  ATP  ATP+KLA
 NM_001004025 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II) (Ppp3r2), mRNA [NM_001004025] KLA 1.03 1.05 1.06 1.08 1.12 1.05 1.04
ATP 1.00 1.02 1.04 1.04 .99 .99 1.01
KLA/ATP 1.04 1.12 1.03 1.09 1.00 .99 1.00
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Ptafr
KLA  ATP  ATP+KLA
 AF004858 platelet activating factor receptor mRNA, partial cds. [AF004858] KLA 1.20 1.24 1.22 1.15 1.15 1.23 1.40
ATP 1.03 1.05 1.04 1.19 1.37 1.33 1.63
KLA/ATP 1.28 1.33 1.17 1.25 1.29 1.50 1.90
Ptafr
KLA  ATP  ATP+KLA
 NM_001081211 platelet-activating factor receptor (Ptafr), mRNA [NM_001081211] KLA 1.73 1.73 1.60 1.31 1.61 1.84 2.08
ATP 1.06 1.10 .98 1.24 2.12 2.22 3.21
KLA/ATP 1.93 1.99 1.47 1.65 1.83 2.58 5.06
Ptger3
KLA  ATP  ATP+KLA
 D17406 mRNA for prostaglandin E receptor EP3 subtype, complete cds [D17406] KLA 1.04 .92 1.04 1.06 .98 .97 1.07
ATP .97 .96 1.06 .97 .99 .98 1.07
KLA/ATP 1.00 1.02 .98 1.00 1.01 1.05 .95
Ptger3
KLA  ATP  ATP+KLA
 NM_011196 prostaglandin E receptor 3 (subtype EP3) (Ptger3), mRNA [NM_011196] KLA 1.06 1.00 1.01 .99 .97 .98 .93
ATP 1.00 .98 .94 .99 1.09 1.10 .97
KLA/ATP 1.01 1.02 .92 .96 1.07 1.30 1.08
Ptgfr
KLA  ATP  ATP+KLA
 AK086563 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930037F10 product:unclassifiable, full insert sequence [AK086563] KLA 1.02 .98 1.02 .98 .99 .95 1.01
ATP .94 1.02 1.02 .96 1.04 1.00 .90
KLA/ATP 1.02 1.07 .99 .87 1.00 1.02 .96
Ptgfr
KLA  ATP  ATP+KLA
 NM_008966 prostaglandin F receptor (Ptgfr), mRNA [NM_008966] KLA 1.07 .96 .99 .99 .97 .97 .98
ATP .94 1.03 .98 1.00 1.03 1.05 1.10
KLA/ATP .95 .97 1.03 1.02 1.02 1.00 .99
Ptk2b
KLA  ATP  ATP+KLA
 NM_172498 PTK2 protein tyrosine kinase 2 beta (Ptk2b), mRNA [NM_172498] KLA 1.34 1.39 1.78 1.70 2.36 2.26 1.77
ATP 1.08 1.21 .59 .69 .65 .71 1.17
KLA/ATP 1.41 1.55 1.07 1.33 1.07 1.24 1.80
Ryr1
KLA  ATP  ATP+KLA
 AK042482 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630095L05 product:RYANODINE RECEPTOR 1 (SKELETAL MUSCLE-TYPE RYANODINE RECEPTOR) (RYR1) (RYR-1) (SKELETAL MUSCLE CALCIUM RELEASE CHANNEL) homolog [Homo sapiens], full KLA 1.61 1.64 1.65 1.73 1.85 1.62 1.13
ATP 1.05 1.11 1.16 1.42 1.40 1.28 1.22
KLA/ATP 1.77 1.70 1.98 2.23 1.96 1.47 1.48
Ryr1
KLA  ATP  ATP+KLA
 AK042482 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630095L05 product:RYANODINE RECEPTOR 1 (SKELETAL MUSCLE-TYPE RYANODINE RECEPTOR) (RYR1) (RYR-1) (SKELETAL MUSCLE CALCIUM RELEASE CHANNEL) homolog [Homo sapiens], full i KLA 1.52 1.58 1.63 1.69 1.73 1.53 1.25
ATP .99 .99 1.07 1.37 1.35 1.30 1.15
KLA/ATP 1.58 1.67 1.84 1.97 1.94 1.65 1.41
Ryr1
KLA  ATP  ATP+KLA
 NM_009109 ryanodine receptor 1, skeletal muscle (Ryr1), mRNA [NM_009109] KLA .94 .93 .89 .91 .82 .86 .88
ATP 1.05 .98 .95 1.08 1.41 1.28 1.15
KLA/ATP .93 .95 .92 1.02 1.62 1.96 2.06
Ryr2
KLA  ATP  ATP+KLA
 BC043140 ryanodine receptor 2, cardiac, mRNA (cDNA clone IMAGE:6822493), complete cds. [BC043140] KLA .97 1.03 1.01 1.03 1.03 1.01 1.05
ATP .99 .98 1.03 1.02 1.01 1.09 1.04
KLA/ATP .98 1.00 .98 1.04 1.04 1.06 1.00
Ryr2
KLA  ATP  ATP+KLA
 NM_023868 ryanodine receptor 2, cardiac (Ryr2), mRNA [NM_023868] KLA 1.04 1.02 1.00 1.00 1.03 .97 .96
ATP .95 1.04 1.00 .94 .98 1.01 1.08
KLA/ATP .99 .97 1.02 1.03 1.00 .98 1.00
Ryr3
KLA  ATP  ATP+KLA
 BC116740 ryanodine receptor 3, mRNA (cDNA clone IMAGE:40126059), complete cds. [BC116740] KLA .99 .95 .96 1.08 1.04 1.01 1.02
ATP 1.06 1.02 1.00 1.03 1.01 .96 1.04
KLA/ATP 1.06 .98 .90 1.06 1.06 .97 1.06
Ryr3
KLA  ATP  ATP+KLA
 NM_177652 ryanodine receptor 3 (Ryr3), mRNA [NM_177652] KLA 1.04 1.02 1.03 1.03 1.04 1.04 1.03
ATP .97 .96 .99 1.06 .98 1.00 1.01
KLA/ATP 1.03 1.02 1.01 1.03 1.02 1.02 1.01
Slc25a31
KLA  ATP  ATP+KLA
 NM_178386 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 (Slc25a31), nuclear gene encoding mitochondrial protein, mRNA [NM_178386] KLA .99 .96 .88 .97 .96 .91 .75
ATP 1.09 .96 .96 1.01 .92 .90 .77
KLA/ATP 1.02 .96 .89 .90 .96 .93 .74
Slc25a4
KLA  ATP  ATP+KLA
 NM_007450 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 (Slc25a4), nuclear gene encoding mitochondrial protein, mRNA [NM_007450] KLA .80 .84 .85 .80 .77 .70 .68
ATP 1.01 1.04 .99 1.00 .81 .46 .60
KLA/ATP .88 .85 .77 .78 .65 .42 .23
Slc25a5
KLA  ATP  ATP+KLA
 NM_007451 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 (Slc25a5), nuclear gene encoding mitochondrial protein, mRNA [NM_007451] KLA .93 .93 .89 .90 .93 .92 1.27
ATP 1.03 1.08 .93 .97 .98 .92 1.06
KLA/ATP .84 .91 .80 .87 .75 .76 .55
Slc8a1
KLA  ATP  ATP+KLA
 AF004666 sodium-calcium exchanger (NCX1) mRNA, complete cds. [AF004666] KLA 1.13 1.10 1.22 1.44 1.52 1.55 1.10
ATP 1.03 1.05 1.22 1.12 .65 .49 .67
KLA/ATP 1.04 1.21 1.30 1.44 .81 .63 1.01
Slc8a1
KLA  ATP  ATP+KLA
 AF108396 sodium/calcium exchanger isoform NaCa3 (Ncx1) mRNA, partial cds. [AF108396] KLA 1.07 1.18 1.30 1.22 1.31 1.39 1.21
ATP 1.03 1.02 1.10 1.07 .88 .91 1.23
KLA/ATP 1.15 1.17 1.14 1.22 .96 1.01 1.77
Slc8a1
KLA  ATP  ATP+KLA
 NM_011406 solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), transcript variant A, mRNA [NM_011406] KLA 1.12 1.16 1.22 1.25 1.35 1.33 1.11
ATP 1.03 1.04 1.07 1.10 .93 .90 1.19
KLA/ATP 1.13 1.24 1.19 1.16 .93 1.06 1.62
Slc8a2
KLA  ATP  ATP+KLA
 NM_148946 solute carrier family 8 (sodium/calcium exchanger), member 2 (Slc8a2), mRNA [NM_148946] KLA 1.14 1.11 1.17 1.21 1.17 1.21 1.09
ATP .96 .87 1.22 1.12 1.15 .96 1.01
KLA/ATP 1.16 1.15 1.30 1.23 1.22 .95 1.00
Slc8a3
KLA  ATP  ATP+KLA
 AK139260 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730083B07 product:solute carrier family 8 (sodium [AK139260] KLA .96 1.03 1.02 .95 .99 1.03 .95
ATP .95 .99 .98 .94 1.02 .96 1.09
KLA/ATP 1.02 .98 1.00 .88 .91 .97 1.03
Slc8a3
KLA  ATP  ATP+KLA
 NM_080440 solute carrier family 8 (sodium/calcium exchanger), member 3 (Slc8a3), mRNA [NM_080440] KLA 1.01 .99 .94 1.03 .98 1.02 1.03
ATP .95 1.01 1.04 .92 .95 1.00 1.05
KLA/ATP .97 .99 1.06 .97 .99 .95 1.06
Sphk1
KLA  ATP  ATP+KLA
 NM_025367 sphingosine kinase 1 (Sphk1), transcript variant 2, mRNA [NM_025367] KLA 2.61 2.50 2.04 1.71 1.19 .91 .74
ATP .94 1.00 2.06 8.09 16.52 12.59 3.53
KLA/ATP 2.64 2.81 3.50 8.13 23.71 16.46 2.22
Sphk2
KLA  ATP  ATP+KLA
 NM_020011 sphingosine kinase 2 (Sphk2), transcript variant 2, mRNA [NM_020011] KLA .64 .74 1.05 1.47 2.15 1.84 1.67
ATP 1.10 1.02 .57 .54 .49 1.29 2.15
KLA/ATP .78 .64 .43 .56 .86 1.90 3.74
Stim1
KLA  ATP  ATP+KLA
 AK086594 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930039F22 product:stromal interaction molecule 1, full insert sequence. [AK086594] KLA .90 .98 .92 .92 .97 .99 .97
ATP 1.01 1.01 .91 .93 .94 .98 .95
KLA/ATP .97 .92 .95 .90 .94 .96 .95
Stim1
KLA  ATP  ATP+KLA
 NM_009287 stromal interaction molecule 1 (Stim1), mRNA [NM_009287] KLA .86 .91 .72 .75 .85 .86 .85
ATP 1.04 1.04 .79 .71 .51 .66 1.04
KLA/ATP .92 .75 .60 .65 .47 .60 1.04
Stim2
KLA  ATP  ATP+KLA
 NM_001081103 stromal interaction molecule 2 (Stim2), mRNA [NM_001081103] KLA 2.06 2.23 2.06 2.17 1.47 1.12 1.54
ATP 1.07 .94 1.17 1.00 1.45 2.27 1.14
KLA/ATP 2.15 2.37 2.63 1.58 1.57 1.47 1.55
Tacr1
KLA  ATP  ATP+KLA
 NM_009313 tachykinin receptor 1 (Tacr1), mRNA [NM_009313] KLA 1.21 1.16 1.23 1.08 1.14 1.12 1.06
ATP 1.05 1.03 1.06 1.01 1.00 1.02 1.09
KLA/ATP 1.16 1.23 1.06 1.22 1.10 1.07 1.08
Tacr2
KLA  ATP  ATP+KLA
 NM_009314 tachykinin receptor 2 (Tacr2), mRNA [NM_009314] KLA 1.04 1.13 1.11 1.14 1.12 1.11 1.06
ATP 1.02 1.00 1.01 1.03 1.05 1.10 1.01
KLA/ATP 1.05 1.10 1.17 1.17 1.06 1.01 1.03
Tacr3
KLA  ATP  ATP+KLA
 NM_021382 tachykinin receptor 3 (Tacr3), mRNA [NM_021382] KLA .97 .98 1.07 1.00 1.01 1.02 .92
ATP 1.01 .99 .99 1.01 1.02 1.01 1.05
KLA/ATP 1.03 1.00 1.02 1.01 .94 1.01 1.00
Tbxa2r
KLA  ATP  ATP+KLA
 NM_009325 thromboxane A2 receptor (Tbxa2r), mRNA [NM_009325] KLA 1.02 1.02 1.03 1.01 1.01 1.02 1.05
ATP .97 .98 1.03 1.09 1.06 1.09 1.01
KLA/ATP 1.00 1.05 1.02 1.04 1.09 1.14 1.12
Tnnc1
KLA  ATP  ATP+KLA
 NM_009393 troponin C, cardiac/slow skeletal (Tnnc1), mRNA [NM_009393] KLA .52 .57 .60 .71 .91 1.03 1.71
ATP .92 .70 .67 .76 1.70 1.56 4.25
KLA/ATP .57 .55 .60 .66 1.03 .86 2.98
Tnnc2
KLA  ATP  ATP+KLA
 NM_009394 troponin C2, fast (Tnnc2), mRNA [NM_009394] KLA 1.28 1.29 1.19 1.43 1.25 1.41 1.35
ATP 1.00 .97 1.05 1.26 1.38 1.19 1.08
KLA/ATP 1.21 1.24 1.35 1.38 2.06 1.52 1.39
Trhr
KLA  ATP  ATP+KLA
 NM_013696 thyrotropin releasing hormone receptor (Trhr), mRNA [NM_013696] KLA 1.02 1.02 1.03 1.02 .97 .96 .95
ATP 1.07 .94 .98 1.01 .99 .99 .96
KLA/ATP 1.02 .99 .99 1.00 .99 .94 .94
Trhr2
KLA  ATP  ATP+KLA
 NM_133202 thyrotropin releasing hormone receptor 2 (Trhr2), mRNA [NM_133202] KLA .99 1.01 1.00 1.02 .98 1.07 1.08
ATP .96 1.02 1.01 1.02 .95 .97 .98
KLA/ATP 1.01 .96 1.00 1.04 .97 1.00 .97
Vdac1
KLA  ATP  ATP+KLA
 NM_011694 voltage-dependent anion channel 1 (Vdac1), mRNA [NM_011694] KLA .85 .86 .95 .80 .69 .62 .76
ATP .93 1.01 1.32 1.01 .96 .82 .57
KLA/ATP .81 .85 1.05 .78 .78 .78 .48
Vdac2
KLA  ATP  ATP+KLA
 NM_011695 voltage-dependent anion channel 2 (Vdac2), mRNA [NM_011695] KLA .92 .89 .80 .96 .85 .97 .83
ATP .84 .72 .75 .54 .52 .48 .72
KLA/ATP .74 .68 .71 .48 .69 .59 .37
Vdac3
KLA  ATP  ATP+KLA
 NM_011696 voltage-dependent anion channel 3 (Vdac3), mRNA [NM_011696] KLA 1.09 1.11 1.13 1.15 1.12 1.21 1.45
ATP .95 .96 1.06 .91 .91 1.36 1.11
KLA/ATP 1.06 1.06 1.20 1.03 1.11 1.07 1.12